News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
344 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17924)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
2 (18)
3 (192)
4 (399)
5 (344)
6 (307)
7 (143)
8 (3)
9 (40)
10 (389)
11 (192)
12 (199)
13 (188)
14 (96)
15 (3)
16 (29)
17 (74)
18 (340)
19 (185)
20 (212)
21 (85)
22 (1)
23 (15)
24 (197)
25 (192)
26 (163)
27 (186)
28 (90)
29 (1)
30 (4)
31 (163)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Genetown
NeuroMetrix to Present at H.C. Wainwright BioConnect Conference 2022
NeuroMetrix, Inc. announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the H.C. Wainwright BioConnect Conference to be held virtually on January 10-13, 2022.
January 5, 2022
·
1 min read
Business
PacBio and Care4Rare Consortium Collaborate on Rare Disease Research StudyThe study will evaluate the impact of high-resolution genomes generated on PacBio technology in studying unsolved rare disease cases
PacBio, a leading provider of high-quality, long-read sequencing platforms, and the Care4Rare Canada Consortium (Care4Rare) announce today they are collaborating to study some of the most complex unexplained rare disease cases within Canada.
January 5, 2022
·
4 min read
Lone Star Bio
Lumos Pharma to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company will present at the H.C. Wainwright Virtual BIOCONNECT Conference being held January 10-13, 2022.
January 5, 2022
·
1 min read
BioMidwest
Neovasc Announces First Patient Enrollment in COSIRA-II Trial
Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced enrollment of the first patient in the COSIRA-II clinical trial. COSIRA-II (COronary SInus Reducer for the Treatment of Refractory Angina) is a pivotal trial that will study the Neovasc Reducer™ (“Reducer”), designed to reduce angina symptoms in patients with refractory angina.
January 5, 2022
·
10 min read
BioMidwest
Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022
Sonoma Pharmaceuticals, Inc. announced that it will be featured as a presenting company at the H.C. Wainwright BioConnect Conference.
January 5, 2022
·
4 min read
Policy
Colibri™ Automated Specimen Workup Instrument by COPAN Receives FDA 510(k) Clearance for Use with MALDI-TOF Mass Spectrometry Analyzers
COPAN Diagnostics is proud to announce the FDA clearance of Colibri™, an automated processor that is a complementary part of WASPLab®, COPAN’s full laboratory automation system.
January 5, 2022
·
4 min read
Genetown
Scorpion Therapeutics Receives BioSpace NextGen Bio “Class of 2022” Recognition
Scorpion Therapeutics, Inc. has been selected by BioSpace to join its NextGen Bio “Class of 2022.” The recognition from BioSpace, a life sciences industry news outlet and career hub, highlights top up-and-coming biopharmaceutical companies to watch in the new year.
January 5, 2022
·
2 min read
Pharm Country
Annovis Bio Announces Official Unique Name Buntanetap for Lead Candidate ANVS401
Buntanetap, previously known as ANVS401 or Posiphen, is sometimes mistaken for phenserine.
January 5, 2022
·
4 min read
Policy
Median Technologies Announces Outstanding Lung Nodule Detection (CADe1) Performance for iBiopsy® Lung Cancer Screening
Median Technologies (ALMDT:PA) announces outstanding performance for its iBiopsy® Lung Cancer Screening (LCS) CADe algorithm in detecting potentially cancerous lung nodules.
January 5, 2022
·
5 min read
Business
Invenra, Inc. Appoints Daniel S. Pereira, Ph.D., as Chief Scientific Officer
Invenra, Inc., a biotechnology company focused on the discovery and development of multispecific antibodies for immuno-oncology, today announced the appointment of Daniel S. Pereira, Ph.D., as Chief Scientific Officer.
January 5, 2022
·
3 min read
Previous
25 of 35
Next